MREO Insider Trading

Insider Ownership Percentage: 4.13%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $298,283.04

Mereo BioPharma Group Insider Trading History Chart

This chart shows the insider buying and selling history at Mereo BioPharma Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mereo BioPharma Group Share Price & Price History

Current Price: $3.86
Price Change: Price Decrease of -0.12 (-3.02%)
As of 06/24/2024 03:29 PM ET

This chart shows the closing price history over time for MREO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Mereo BioPharma Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/22/2024Alexandra Hughes-WilsonInsiderSell100,432$2.97$298,283.0432,568View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Mereo BioPharma Group (NASDAQ:MREO)

62.83% of Mereo BioPharma Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MREO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Mereo BioPharma Group Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2024Janus Henderson Group PLC5,120,573$16.95M0.0%N/A3.651%Search for SEC Filing on Google Icon
5/16/2024Knoll Capital Management LLC260,470$0.86M0.5%+62.3%0.186%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD991,971$3.27M0.0%N/A0.707%Search for SEC Filing on Google Icon
5/13/2024Index Fund Advisors Inc.30,000$99K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/9/2024Monaco Asset Management SAM405,000$1.34M0.4%-40.1%0.324%Search for SEC Filing on Google Icon
5/8/2024Advisors Preferred LLC8,262$28K0.0%N/A0.007%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC16,221$54K0.0%N/A0.013%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets17,435$58K0.0%+581,066.7%0.014%Search for SEC Filing on Google Icon
2/15/2024Forefront Analytics LLC36,124$83K0.0%-45.0%0.029%Search for SEC Filing on Google Icon
2/14/2024Rubric Capital Management LP13,552,997$31.31M0.6%+16.7%10.843%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC351,905$0.81M0.1%+751.5%0.282%Search for SEC Filing on Google Icon
2/9/2024Primecap Management Co. CA54,000$0.13M0.0%-31.6%0.043%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM676,494$1.56M0.5%+13.6%0.541%Search for SEC Filing on Google Icon
2/2/2024Golden State Equity Partners20,300$47K0.0%+41.0%0.016%Search for SEC Filing on Google Icon
1/31/2024abrdn plc1,551,082$3.58M0.0%N/A1.241%Search for SEC Filing on Google Icon
1/18/2024Clear Harbor Asset Management LLC59,754$0.14M0.0%-6.3%0.048%Search for SEC Filing on Google Icon
11/15/2023Tejara Capital Ltd3,215,001$4.15M2.4%+5.8%2.572%Search for SEC Filing on Google Icon
11/15/2023Rock Springs Capital Management LP7,676,481$9.90M0.3%+9.0%6.142%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.800,000$1.03M0.0%N/A0.640%Search for SEC Filing on Google Icon
11/14/2023683 Capital Management LLC6,000,000$7.74M0.6%+11.1%4.800%Search for SEC Filing on Google Icon
11/14/2023Primecap Management Co. CA79,000$0.10M0.0%-49.9%0.063%Search for SEC Filing on Google Icon
11/13/2023Tejara Capital Ltd3,215,001$4.15M3.1%+5.8%2.572%Search for SEC Filing on Google Icon
11/9/2023Formidable Asset Management LLC331,914$0.43M0.1%N/A0.266%Search for SEC Filing on Google Icon
11/8/2023Forefront Analytics LLC65,649$85K0.0%-20.7%0.053%Search for SEC Filing on Google Icon
11/7/2023Monaco Asset Management SAM595,729$0.77M0.2%-15.6%0.477%Search for SEC Filing on Google Icon
11/6/2023Privium Fund Management UK Ltd24,726$32K0.0%-86.0%0.020%Search for SEC Filing on Google Icon
10/26/2023Clear Harbor Asset Management LLC63,754$82K0.0%+12.3%0.051%Search for SEC Filing on Google Icon
8/14/2023683 Capital Management LLC5,400,000$7.13M0.5%+170.0%4.320%Search for SEC Filing on Google Icon
8/14/2023Rock Springs Capital Management LP7,042,391$9.30M0.2%+12.8%5.634%Search for SEC Filing on Google Icon
8/14/2023Mangrove Partners5,531,547$7.30M0.5%N/A4.426%Search for SEC Filing on Google Icon
8/11/2023Rubric Capital Management LP11,616,120$15.33M0.7%+12.1%9.294%Search for SEC Filing on Google Icon
8/11/2023Tejara Capital Ltd3,037,971$4.01M2.0%+24.7%2.431%Search for SEC Filing on Google Icon
8/8/2023Monaco Asset Management SAM705,729$0.93M0.3%-46.4%0.565%Search for SEC Filing on Google Icon
8/3/2023PFG Investments LLC31,500$42K0.0%-33.7%0.025%Search for SEC Filing on Google Icon
7/26/2023Privium Fund Management B.V.177,200$0.23M0.1%N/A0.142%Search for SEC Filing on Google Icon
7/21/2023Clear Harbor Asset Management LLC56,754$75K0.0%-29.7%0.045%Search for SEC Filing on Google Icon
5/12/2023Tejara Capital Ltd2,435,806$1.72M0.9%+11.3%1.949%Search for SEC Filing on Google Icon
5/12/2023Forefront Analytics LLC83,700$59K0.0%+13.9%0.067%Search for SEC Filing on Google Icon
5/11/2023PFG Investments LLC47,500$34K0.0%N/A0.038%Search for SEC Filing on Google Icon
5/9/2023Formidable Asset Management LLC331,914$0.23M0.0%+15.2%0.266%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC125,000$94K0.0%N/A0.100%Search for SEC Filing on Google Icon
2/13/2023Forefront Analytics LLC73,500$55K0.0%-34.8%0.059%Search for SEC Filing on Google Icon
2/3/2023Monaco Asset Management SAM2,049,661$1.54M0.4%+998.1%1.640%Search for SEC Filing on Google Icon
1/31/2023Monaco Asset Management SAM2,049,661$1.54M0.5%+998.1%1.640%Search for SEC Filing on Google Icon
1/20/2023Clear Harbor Asset Management LLC84,000$63K0.0%-42.1%0.067%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.9,829,354$8.46M0.0%-2.1%7.864%Search for SEC Filing on Google Icon
11/14/2022Clearline Capital LP3,957,135$3.41M0.4%+29.4%3.166%Search for SEC Filing on Google Icon
11/14/2022Rubric Capital Management LP10,366,120$8.93M0.4%-38.1%8.294%Search for SEC Filing on Google Icon
11/14/2022Forefront Analytics LLC112,800$96K0.1%+48.7%0.090%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC33,880$29K0.0%N/A0.027%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC39,470$34K0.0%+97.4%0.032%Search for SEC Filing on Google Icon
11/1/2022Privium Fund Management UK Ltd177,200$0.15M0.2%N/A0.142%Search for SEC Filing on Google Icon
10/31/2022Monaco Asset Management SAM186,656$0.16M0.1%N/A0.160%Search for SEC Filing on Google Icon
10/25/2022Clear Harbor Asset Management LLC145,000$0.13M0.0%-10.5%0.124%Search for SEC Filing on Google Icon
8/16/2022Formidable Asset Management LLC275,556$0.31M0.1%N/A0.236%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC1,096,513$1.23M0.3%-9.9%0.937%Search for SEC Filing on Google Icon
8/15/2022Clearline Capital LP3,058,596$3.43M0.4%+135.0%2.615%Search for SEC Filing on Google Icon
8/15/2022Point72 Asset Management L.P.10,035,970$11.24M0.0%-12.7%8.579%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC615,856$0.20M0.0%-32.8%0.526%Search for SEC Filing on Google Icon
8/11/2022Primecap Management Co. CA321,660$0.36M0.0%-2.8%0.275%Search for SEC Filing on Google Icon
8/10/2022Forefront Analytics LLC75,850$83K0.0%N/A0.065%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC156,195$0.18M0.1%-33.7%0.134%Search for SEC Filing on Google Icon
7/20/2022Clear Harbor Asset Management LLC162,000$0.19M0.0%+589.4%0.138%Search for SEC Filing on Google Icon
5/17/2022Rock Springs Capital Management LP6,074,943$6.80M0.2%+8.8%5.193%Search for SEC Filing on Google Icon
5/16/2022Clearline Capital LP1,301,783$1.46M0.2%+89.7%1.113%Search for SEC Filing on Google Icon
5/16/2022J. Goldman & Co LP217,051$0.24M0.0%+221.6%0.186%Search for SEC Filing on Google Icon
5/16/2022Eversept Partners LP370,170$0.42M0.0%+42.7%0.316%Search for SEC Filing on Google Icon
5/16/2022Maven Securities LTD544,458$0.61M0.0%+72.6%0.465%Search for SEC Filing on Google Icon
2/15/2022Rubric Capital Management LP14,914,447$23.86M1.1%+32.0%22.001%Search for SEC Filing on Google Icon
2/15/2022Sender Co & Partners Inc.333,904$0.53M0.3%N/A0.493%Search for SEC Filing on Google Icon
2/15/2022Shay Capital LLC48,052$77K0.0%N/A0.071%Search for SEC Filing on Google Icon
2/15/2022Commodore Capital LP1,954,970$3.13M0.7%-0.9%2.884%Search for SEC Filing on Google Icon
2/14/2022Clearline Capital LP686,292$1.10M0.1%N/A1.012%Search for SEC Filing on Google Icon
2/14/2022Bluefin Capital Management LLC37,300$60K0.0%N/A0.055%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.10,610,000$16.98M0.1%+6.4%15.651%Search for SEC Filing on Google Icon
2/14/2022Eversept Partners LP259,470$0.42M0.0%-71.2%0.383%Search for SEC Filing on Google Icon
2/14/2022Maven Securities LTD315,457$0.51M0.0%N/A0.465%Search for SEC Filing on Google Icon
2/9/2022Insight Advisors LLC PA15,712$25K0.0%-55.5%0.023%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC15,646$25K0.0%N/A0.023%Search for SEC Filing on Google Icon
1/21/2022Clear Harbor Asset Management LLC17,000$27K0.0%N/A0.025%Search for SEC Filing on Google Icon
11/16/2021Suvretta Capital Management LLC9,142,067$22.12M0.4%+5.7%13.486%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC820,793$1.99M0.0%-38.1%1.211%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC1,434,544$3.47M0.0%-13.8%2.116%Search for SEC Filing on Google Icon
11/16/2021Commodore Capital LP1,972,958$4.78M1.3%-4.2%2.910%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.9,975,000$24.14M0.1%-1.3%14.714%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP4,832,978$11.70M0.2%+6.4%7.129%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP899,569$2.18M0.2%N/A1.327%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC398,900$0.97M0.0%+39.9%0.588%Search for SEC Filing on Google Icon
11/12/2021Rubric Capital Management LP11,300,000$27.35M0.8%+99.6%16.669%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC32,788$79K0.0%-78.4%0.048%Search for SEC Filing on Google Icon
11/12/2021Primecap Management Co. CA339,600$0.82M0.0%-30.5%0.501%Search for SEC Filing on Google Icon
11/12/2021Oppenheimer & Co. Inc.19,000$46K0.0%N/A0.028%Search for SEC Filing on Google Icon
11/5/2021Resources Investment Advisors LLC.36,043$87K0.0%+177.3%0.053%Search for SEC Filing on Google Icon
11/2/2021Valeo Financial Advisors LLC22,506$54K0.0%-30.8%0.033%Search for SEC Filing on Google Icon
8/27/2021Endurant Capital Management LP756,915$2.40M0.7%-43.5%1.117%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP44,682$0.14M0.0%-39.3%0.066%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC944,308$0.35M0.0%-17.6%1.393%Search for SEC Filing on Google Icon
8/17/2021Perceptive Advisors LLC1,696,068$5.38M0.1%-71.7%2.502%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP46,984$0.15M0.0%N/A0.069%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC1,663,950$5.28M0.0%-35.7%2.455%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Mereo BioPharma Group logo
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.
Read More on Mereo BioPharma Group

Today's Range

Now: $3.86
Low: $3.82
High: $4.02

50 Day Range

MA: $3.23
Low: $2.58
High: $4.25

52 Week Range

Now: $3.86
Low: $1.07
High: $4.50

Volume

334,023 shs

Average Volume

1,432,404 shs

Market Capitalization

$541.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

Who are the company insiders with the largest holdings of Mereo BioPharma Group?

Mereo BioPharma Group's top insider investors include:
  1. Alexandra Hughes-Wilson (Insider)
Learn More about top insider investors at Mereo BioPharma Group.

Who are the major institutional investors of Mereo BioPharma Group?

Mereo BioPharma Group's top institutional investors include:
  1. Janus Henderson Group PLC — 3.65%
  2. Price T Rowe Associates Inc. MD — 0.71%
  3. Monaco Asset Management SAM — 0.32%
  4. Knoll Capital Management LLC — 0.19%
  5. Index Fund Advisors Inc. — 0.02%
  6. BNP Paribas Financial Markets — 0.01%
Learn More about top institutional investors of Mereo BioPharma Group stock.

Which major investors are selling Mereo BioPharma Group stock?

In the previous quarter, MREO stock was sold by these institutional investors:
  1. Monaco Asset Management SAM

Which major investors are buying Mereo BioPharma Group stock?

Within the last quarter, MREO stock was bought by institutional investors including:
  1. Janus Henderson Group PLC
  2. Price T Rowe Associates Inc. MD
  3. Knoll Capital Management LLC
  4. Index Fund Advisors Inc.
  5. BNP Paribas Financial Markets
  6. SG Americas Securities LLC
  7. Advisors Preferred LLC